Skip to main content
SpringerLink
Log in

Effects of Inhaled Salbutamol and Oxitropium Bromide on Cardiopulmonary Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease and Coronary Artery Disease

  • Conference paper
Computerized Cardiopulmonary Exercise Testing

  • 85 Accesses

Abstract

In patients with chronic obstructive pulmonary disease (COPD), exercise performance is limited due to reduced ventilatory capacity [6, 9, 15, 23]. Airflow obstruction and its quantitative impact on exercise tolerance is still the subject of investigation [6, 9, 20, 25, 31, 34, 36]. Inhalative therapy of COPD with sympathomimetic and anticholinergic bronchodilators is established [1, 31]. The effects of these agents on exercise performance, however, are controversially discussed [9, 10, 19]. Tachycardia and increase of myocardial oxygen consumption are well-known side-effects of these substances [13, 35].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 149.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 199.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis (1987); 136: 225

    Article  Google Scholar 

  2. Andersen G (1983) Anticholinergic drugs in airways obstruction. Postgrad Med J 59: 64

    Google Scholar 

  3. Anthonisen NR, Wright EC, IPPB Trial Group (1986) Bronchodilator response in chronic obstructive pulmonary disease. Am Rev Respir Dis 133: 814

    Google Scholar 

  4. Bauer R (1985) Zur Pharmakologie des Bronchospasmolytikums Oxitropiumbromid. Arzneim Forsch 35: 435

    CAS  Google Scholar 

  5. Beaver WL, Wasserman K, Whipp BJ (1986) A new method for detecting anaerobic threshold by gas exchange. J Appl Phyiol 60: 2020

    CAS  Google Scholar 

  6. Belman MJ (1986) Exercise in chronic obstructive pulmonary disease. Clinics Chest Med 7: 585

    CAS  Google Scholar 

  7. Braunwald E (ed) (1988) Heart disease 3rd edition Philadelphia WB Saunders

    Google Scholar 

  8. Choo-Kang YFJ, Simpson WT, Grant IWB (1969) Controlled comparison of the bronchodilator effect of three ß-adrenergic stimulant drugs administered by inhalation to patients with asthma. Br Med J 2: 287

    Article  PubMed  CAS  Google Scholar 

  9. Clark JC, Cochrane LM (1988) Assessment of work performance in asthma for determination of cardiorespiratory fitness and training capacity. Thorax 43: 745

    Article  PubMed  CAS  Google Scholar 

  10. Conolly CK, Chan NS (1987) Salbutamol and ipratropium in partially reversible airway obstruction. Br J Dis Chest 81: 55

    Article  Google Scholar 

  11. Firstrater E, Mizrachi E, Topilski M (1981) The effect of vagolytic drugs on airway obstruction in patients with bronchial asthma. Ann Allergy 46: 332

    Google Scholar 

  12. Floher E, Bischoff KO (1989) Oxitropium bromide, a new anticholinergic drug in a dose-response and placebo comparison in obstructive airway disease. Respiration 38: 98

    Article  Google Scholar 

  13. Goodman LS, Gilman A (1989) The pharmacological basis of therapeutics (7th ed.) New York, Mc Millan

    Google Scholar 

  14. Gross NJ, Skorodin MS (1984) Anticholinergic, antimuscarinic bronchodilators. Am Rev Respir Dis 129: 856

    PubMed  CAS  Google Scholar 

  15. Gross NJ (1986) COPD: a disease of reversible airflow obstruction. Am Rev Respir Dis 113: 725

    Google Scholar 

  16. Gross NJ, Bankwala Z: Effects of an anticholinergic bronchodilator on arterial blood gases of hypoxemic patients with chronic obstructive pulmonary disease (1987) comparison with a betaadrenergic agent. Am Rev Respir Dis 136: 1091

    Google Scholar 

  17. Guyatt GH, Towsend M, Keller J, Singer J, Nogradi S (1989) Measuring functional status in chronic lung disease: conclusions from a randomized control trial. Respir Med 83: 293

    Article  PubMed  CAS  Google Scholar 

  18. Hensley MJ, O’Cain CF, McFadden ER jr, Ingram RH jr (1978) Distribution of bronchodilatation in normal subjects: beta agonist versus atropine. J Appl Physiol 45: 778

    PubMed  CAS  Google Scholar 

  19. Ingeman-Hansen T, Bundgaard A, Halkjer-Kristensen J, Siggard-Andersen J, Weeke B (1980) Maximal oxygen consumption rate in patients with bronchial asthma — the effect of ßz-adrenoceptor stimulation. Scand J Clin Lab Invest 40: 99

    Article  Google Scholar 

  20. Jones NL, Jones G, Edwards RHT (1971) Exercise tolerance in chronic airway obstruction. Am Rev Respir Dis 103: 477

    PubMed  CAS  Google Scholar 

  21. Kennedy MCS, Simpson WT (1969) Human pharmacological and clinical studies on salbutamol: A specific 13-adrenergic bronchodilator. Br J Dis Chest 2: 165

    Article  Google Scholar 

  22. Leitch AG, Hopkin JM, Ellis DA, Merchant S, McHardy GJR (1978) The effect of aerosol ipratropium bromide and salbutamol on exercise tolerance in chronic bronchitis. Thorax 33: 711 )

    Article  PubMed  CAS  Google Scholar 

  23. Loke J, Mahler D, Man SFP, Wiedeman HP, Matthay RA (1984) Exercise impairment in chronic obstructive pulmonary disease. Clin Chest Med 5: 121

    PubMed  CAS  Google Scholar 

  24. Lulling J, Delwiche JP, Prignot J (1981) Early bronchodilating effect of oxitropium bromide in comparison with ipratropium bromide. Respiration 42: 188

    Article  PubMed  CAS  Google Scholar 

  25. McGavin CR, Artvinly M, Naoe H, McHardy GJR (1978) Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease. Br Med J 2: 241

    Article  PubMed  CAS  Google Scholar 

  26. Minette A, Marcq M (1979) Oxitropium bromide, an advance in the field of anticholinergic bronchodilating treatments. Preliminary results. Rev Inst Hyg Mines 34: 115

    Google Scholar 

  27. Mols P, Ham H, Naeije N, Dechamps P, Huyn Ch, Vandenbosch L, Sergysels R (1988) How does salbutamol improve the ventricular performance in patients with chronic obstructive pulmonary disease? Cardiovasc Pharmacol 12: 127

    Article  CAS  Google Scholar 

  28. Neuberg GW, Friedman SH, Weiss MB, Herman MV (1988) Cardiopulmonary exercise testing. The clinical value of gas exchange data. Arch Intern Med 148: 2221

    Google Scholar 

  29. Neuberg GW (1990) Cardiopulmonary exercise testing. 97: 257

    CAS  Google Scholar 

  30. Pakes GE (1984) Anticholinergic drugs. In: Buckle DR, Smith H (eds.): Development of antiasthmatic drugs. London: Butterworths

    Google Scholar 

  31. Paterson JW, Woolcock AJ, Shenfield GM (1979) Bronchodilator drugs. Am Rev Resp Dis 120: 1149

    PubMed  CAS  Google Scholar 

  32. Petrie GR, Palmer KNV (1975) Comparison of aerosol ipratropium bromide and salbutamol in chronic bronchitis and asthma. Br Med J 1: 430

    Article  PubMed  CAS  Google Scholar 

  33. Riding WD, Dinda P, Catterjee SS (1970) The bronchodilator and cardiac effects of five pressure-packed aerosols in asthma. Br J Dis Chest 64: 37

    Article  PubMed  CAS  Google Scholar 

  34. Spiro SG, Hahn HL, Edwards RHT, Pride NB (1975) An analysis of the physiological strain of exercise in patients with chronic obstructive bronchitis. Thorax 30: 415

    Article  PubMed  CAS  Google Scholar 

  35. Svedmyr N (1977) Treatment with beta-adrenostimulants. Scand J Resp Dis 58: 5

    Google Scholar 

  36. Swinburn CR, Wakefield JM, Jones PW (1985) Performance, ventilation and oxygen consumption in three different types of exercise tests in patients with chronic obstructive lung disease. Thorax 40: 581

    Article  PubMed  CAS  Google Scholar 

  37. Wasserman K (1987) Determinants and detection of anaerobic threshold and consequences of exercise above it. Circulation 76 (suppl VI): 29

    Google Scholar 

  38. Wasserman K, Hansen JE, Sue DY, Whipp BJ (1987) Principles of exercise testing and interpretation. Philadelphia: Lea and Febiger

    Google Scholar 

  39. Weber KT, Janicki JS (1986) Cardiopulmonary exercise testing. Philadelphia: WB Saunders

    Google Scholar 

  40. Whipp BJ (1987) Dynamics of pulmonary gas exchange. Circulation (1987) 76 (suppl VI): 18

    Google Scholar 

  41. Zar JH (1984) Biostatistical analysis ( 2nd ed. ), Prentice-Hall, Inc., Englewood Cliffs, New Jersey

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Clinic I, RWTH Aachen, Pauwelsstr. 30, 5100, Aachen, Germany

    Franz van Erckelens M.D., Th. Hürter, Th. Eitelberg, U. Krobok, Ch. Reupcke, E. Schmitz, M. Sigmund & P. Hanrath

Authors
  1. Franz van Erckelens M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Th. Hürter
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Th. Eitelberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. U. Krobok
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Ch. Reupcke
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. E. Schmitz
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. M. Sigmund
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. P. Hanrath
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Klinik III für Innere Medizin, Universität Köln, Joseph-Stelzmann-Str. 9, 5000, Köln 41, Deutschland

    U. J. Winter  & H. W. Höpp  & 

  2. Harbor UCLA, 1000 W. Carson Street, 90509, Torrance, CA, USA

    K. Wasserman

  3. II. Medizinische Klinik und Poliklinik, Universität Mainz, Langenbeckstraße 1, 6500, Mainz, Deutschland

    N. Treese

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt

About this paper

Cite this paper

van Erckelens, F. et al. (1991). Effects of Inhaled Salbutamol and Oxitropium Bromide on Cardiopulmonary Exercise Capacity in Patients with Chronic Obstructive Pulmonary Disease and Coronary Artery Disease. In: Winter, U.J., Wasserman, K., Höpp, H.W., Treese, N. (eds) Computerized Cardiopulmonary Exercise Testing. Steinkopff. https://doi.org/10.1007/978-3-642-85404-0_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-85404-0_17

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-642-85406-4

  • Online ISBN: 978-3-642-85404-0

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation